Search the hub
Showing results for tags 'Medication'.
Found 1,130 results
-
Content Article
PHE: Become an antibiotic guardian
Claire Cox posted an article in Medicine management
The Antibiotic Guardian campaign is led by Public Health England (PHE) in collaboration with the Devolved Administrations (Scotland, Wales and Northern Ireland); the Department for Environment Food and Rural Affairs (DEFRA) and professional bodies/ organisations towards the ‘One Health’ initiative. Antibiotic resistance is one of the biggest threats facing us today. Without effective antibiotics many routine treatments will become increasingly dangerous. Setting broken bones, basic operations, even chemotherapy and animal health all rely on access to antibiotics that work. To slow resistance we need to cut the unnecessary use of antibiotics. The Antibiotic Guardian invite the public, students and educators, farmers, the veterinary and medical communities and professional organisations, to become Antibiotic Guardians. -
Content ArticleKathleen Sutcliffe is a Bloomberg Distinguished Professor at Johns Hopkins University and the co-author of a forthcoming book Still not safe: patient safety and the middle-managing of American medicine (Oxford University Press).
-
Content ArticlePresentation from Dr Devina Halsall, NHS England & NHS Improvement Northwest Region, at the 'A New Strategy for Patient Safety - Insight, Involvement, Improvement' conference held in Manchester on the 16 October 2019.
-
Content ArticleElectronic health records (EHR) can improve safety via computerised physician order entry with clinical decision support, designed in part to alert providers and prevent potential adverse drug events at entry and before they reach the patient. However, early evidence suggested performance at preventing adverse drug events was mixed. In this study published in BMJ Quality & Safety, Bates et al. used data from 1527 hospitals in the USA from 2009 to 2016 who took a safety performance assessment test using simulated medication orders to test how well their EHR prevented medication errors with potential for patient harm. Results found that the average hospital EHR system correctly prevented only 54.0% of potential adverse drug events tested on the 44-order safety performance assessment in 2009; this rose to 61.6% in 2016. Hospitals that took the assessment multiple times performed better in subsequent years than those taking the test the first time, from 55.2% in the first year of test experience to 70.3% in the eighth, suggesting efforts to participate in voluntary self-assessment and improvement may be helpful in improving medication safety performance. The authors conclude that medication order safety performance has improved over time but is far from perfect. The specifics of EHR medication safety implementation and improvement play a key role in realising the benefits of computerising prescribing, as organisations have substantial latitude in terms of what they implement. Intentional quality improvement efforts appear to be a critical part of high safety performance and may indicate the importance of a culture of safety.
-
Content ArticleThe Healthcare and Safety Investigation Branch (HSIB) identified a significant safety risk posed by the communication and transfer of information between secondary care, primary care and community pharmacy relating to medicines at the time of hospital discharge. A reference event was identified that resulted in a patient inadvertently receiving two anticoagulant medications at the same time, possibly causing an episode of gastrointestinal (digestive tract) bleeding. Increasingly, healthcare facilities in primary and secondary care are introducing digital solutions (electronic prescribing and medicines administration (ePMA) systems) to improve medicines safety. However, analysis of the reference event identified how ePMA systems can create their own risks – risks that will need to be addressed as these systems become more widespread. Other risk factors relating to prescribing and the discharge of the patient, including medicines reconciliation, availability of pharmacy services and weekend working, were identified during the investigation.
-
Content ArticleFollowing the 'A New Strategy for Patient Safety - Insight, Involvement, Improvement' conference held in Manchester on the 16 October 2019, chaired by Helen Hughes of Patient Safety Learning, I am pleased to share the speaker presentations on the hub. A new London conference has been announced for 29 April 2020. Telephone: 0161 376 9007; Email: info@openforumevents.co.uk for further information.
- Posted
- 1 comment
-
- (and 2 more)
-
Content Article
The Neptune story so far
Neptune posted an article in Other health and care software
Winner of Patient Safety Learning's 'Data and Insight' 2019 award, Neptune is a drug testing monitoring software. Catherine tells the story of Neptune's journey from initial idea to implementation. -
Content Article
Falsified medicines and medical devices: MHRA campaign
Patient Safety Learning posted an article in Medication
Fake medicines and medical devices bought online can lead to serious negative health consequences. Buying from dodgy websites also increases the risk of being ripped off through credit card fraud or having your identity stolen. The #FakeMeds campaign, run by Medicines and Healthcare products Regulatory Agency (MHRA), helps you protect your health and money by providing quick and easy tools so you can avoid fake medical products when you shop online. -
Content Article
Bottle of Lies by Katherine Eban
Patient Safety Learning posted an article in Recommended books and literature
The troubles of Indian pharma companies abroad raise questions about the domestic drug regulator. Although Bottle of Lies, a book about the quality problems plaguing generic drugs, focuses on medicines intended for American consumers, the real and continuing victims of the failings described in the book are consumers in developing countries, including Indians. In May 2013, soon after the erstwhile Ranbaxy Laboratories admitted in an American court to selling adulterated drugs, journalist Katherine Eban published a gripping 10,000-word account of the saga in Fortune magazine. But the story left Eban wondering if Ranbaxy was an isolated case. Could there be more rotten eggs, she asked, given the United States Food & Drugs Administration’s (FDA) lax policing of overseas manufacturers? Bottle of Lies is the result of the multi-year investigation that followed. -
Content ArticleDrug monitoring is a cumbersome, time consuming (expensive) and somewhat inaccurate process. The challenge set to ESC Software by a GP was to make an IT solution that was easy to use, comprehensive and reliable that would monitor patient testing to improve safety.
-
Content ArticleThe Canterbury Renal Unit is situated at Kent and Canterbury Hospital and provides renal services for the East Kent, Medway and Maidstone areas. There are currently 680 transplant patients currently being followed up. There have been a number of immunosuppression related prescribing errors in the surrounding hospitals. Indeed, one such error occurred in the renal unit itself, when a transplant patient had prednisolone inadvertently withheld resulting in rejection of the kidney. Thus, a group of 12 transplant patients attended a co-production group to discuss the problems and potential solutions.
-
Content Article
The NHS Patient Safety strategy has a hole in it
Claire Cox posted an article in Medicine management
David Cousins, a consultant in safe medication practice, discusses in a correspondence to The Pharmaceutical Journal how the NHS may have forgotten its safety memory in not addressing important medication risks. Since the introduction of the NHS Patient Safety Strategy for England in July 2019, Cousins states that the NHS is not transparent enough to identify medication risks and calls for safeguards to be put in place. -
Content ArticlePrescribing errors affect patient safety, but pharmacists and other healthcare professionals can reduce the risk of them occurring. In this article published in The Pharmaceutical Journal, David Cousins and colleagues describe the most important types of prescribing errors, medicines and situations responsible for causing death and severe harm to patients. It also provides advice on how to avoid these errors occurring.
-
Content Article
MHRA: The Yellow Card Scheme
Claire Cox posted an article in Adverse interactions
The Yellow Card Scheme helps the Medicines and Healthcare products Regulatory Agency (MHRA) monitor the safety of all healthcare products in the UK to ensure they are acceptably safe for patients and those who use them. On the Yellow Card Scheme website you can report a suspected incident or problem. -
Content ArticleThe Institute for Safe Medication Practices (ISMP) is the only US nonprofit organisation devoted entirely to preventing medication errors. In this short video, produced by ISMP in partnership with the Temple University School of Pharmacy, experts discuss current medication safety concerns and offer practical error prevention recommendations.
-
Content ArticleThe Institute for Safe Medication Practices (ISMP) is the only nonprofit organisation in the US devoted entirely to preventing medication errors. In this video, produced by ISMP in partnership with the Temple University School of Pharmacy, experts discuss medication safety concerns and offer practical error prevention recommendations.
-
Content ArticleThe US Institute for Safe Medication Practices (ISMP) is the only nonprofit organisation devoted entirely to preventing medication errors. During its more than 30-year history, ISMP has helped make a difference in the lives of millions of patients and the healthcare professionals who care for them. ISMP is known and respected as the gold standard for medication safety information. It also has served as a vital force for progress. ISMP’s advocacy work alone has resulted in numerous necessary changes in clinical practice, public policy, and drug labelling and packaging.
-
Content ArticleGuidance from the National Institute for Health and Care Excellence (NICE) cites evidence that when people move from one care setting to another, between 30% and 70% of patients have an error or unintentional change to their medicines. This presents a significant risk to their safety. Maintaining safe care as patients move across health and care services is a national priority for the NHS.
-
Content ArticleThe Health Information and Quality Authority (HIQA) is an independent authority established to drive high-quality and safe care for people using our health and social care services in Ireland. HIQA’s mandate to date extends across a specified range of public, private and voluntary sector services. Reporting to the Minister for Health and engaging with the Minister for Children and Youth Affairs, HIQA’s role is to develop standards, inspect and review health and social care services and support informed decisions on how services are delivered.
-
Content ArticleThis professional guidance has been co-produced by the Royal Pharmaceutical Society (RPS) and Royal College of Nursing (RCN) and provides principles-based guidance to ensure the safe administration of medicines by healthcare professionals.
-
Content ArticleGetting the most from medicines for both patients and the NHS is becoming increasingly important as more people are taking more medicines. Medicines prevent, treat or manage many illnesses or conditions and are the most common intervention in healthcare. However, it has been estimated that between 30% and 50% of medicines prescribed for long-term conditions are not taken as intended.
-
Content ArticleThe Medicines and Healthcare products Regulatory Agency (MHRA) regulates medicines, medical devices and blood components for transfusion in the UK. MHRA is an executive agency, sponsored by the Department of Health and Social Care. Recognised globally as an authority in its field, the agency plays a leading role in protecting and improving public health and supports innovation through scientific research and development. The agency has 3 centres: Clinical Practice Research Datalink (CPRD), a data research service that aims to improve public health by using anonymised NHS clinical data the National Institute for Biological Standards and Control (NIBSC), a global leader in the standardisation and control of biological medicines the Medicines and Healthcare products Regulatory Agency (MHRA), the UK’s regulator of medicines, medical devices and blood components for transfusion, responsible for ensuring their safety, quality and effectiveness.
-
Content Article
Patient Stories: Paul's Story (10 March 2013)
Claire Cox posted an article in Patient stories
In 2007, when Paul Richards was diagnosed with non-Hodgkin lymphoma, his family were stunned by the news. This powerful film from Patient Stories is based on the testimony of Lisa, Paul’s wife, who gives a moving account of the events that led to Paul’s death and explores the effects on their family. -
Content ArticleEffectiveness Matters is a summary of reliable research evidence about the effects of important interventions for practitioners and decision makers in the NHS and public health. It is extensively peer reviewed. This issue focuses on reducing harm from polypharmacy (the use of multiple medicines) in older people.
-
Content ArticleGuidance from the Medicines and Healthcare products Regulatory Agency (MHRA), explains how to package medicines for sale and what information you must provide to consumers and healthcare professionals.
